Skip to main content
. Author manuscript; available in PMC: 2017 Apr 19.
Published in final edited form as: Adv Funct Mater. 2016 Feb 1;26(15):2512–2522. doi: 10.1002/adfm.201504879

Figure 9.

Figure 9

Schematic representation of transdermal immunization by HA-OVA conjugates with laser adjuvant. Topically applied HA-OVA conjugates penetrate into the skin through skin barriers and diffuse throughout the skin. Non-ablative fractional laser adjuvant enhances immune response at the dermis layer. Activated dendritic cells (DCs) migrate to draining lymph nodes and induce immunity.